Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_assertion description "[The glucose-lowering effects of glucagon peptide antagonists and antiglucagon neutralising antibodies first demonstrated the potential of glucagon receptor (GCGR) antagonism as a treatment for hyperglycaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_assertion evidence source_evidence_literature NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_assertion SIO_000772 15948676 NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_assertion wasDerivedFrom befree-20140225 NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_assertion wasGeneratedBy ECO_0000203 NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP917641.RAU0O8cfeHhDHXWY7EWrG03s5vtoJ00t42zTnGnzPSyZU130_provenance.